this includes the creation in collaboration with leading united states institutions of three major programmes aimed at development of molecular diagnostics the integrated biobank of luxembourg the luxembourg centre for systems biomedicine and a pilot programme to find and validate biomarkers for use in disease management and therapeutic followup in lung cancer in these and a number of other research programmes were brought together to create the personalized medicine consortium to coordinate and support research in the areas of cancer type diabetes and parkinson s disease respondents also mentioned that commercial development in the area of molecular diagnostics is also promoted through the luxembourg biohealth cluster